Results 51 to 60 of about 734 (129)
ABSTRACT Given the risk of antibody‐mediated rejection, most kidney graft allocation systems define unacceptable antigens to prevent transplantation in the presence of donor‐specific antibodies. Anti‐HLA‐C and anti‐HLA‐DP antibodies are often not included in these algorithms, including the French allocation system, despite growing evidence supporting ...
Margot Lepage +10 more
wiley +1 more source
Abstract Background and Objectives Daratumumab, a therapeutic human anti‐CD38 monoclonal antibody, improves multiple myeloma outcomes but interferes with pre‐transfusion testing by binding CD38 on reagent red blood cells (RBCs), potentially masking clinically significant alloantibodies.
Arnaud Reggiani +30 more
wiley +1 more source
Background: We report here the results of surveys for external quality assessment of blood bank tests performed in 2009. Methods: Survey specimens were sent three times to 488, 491 and 490 participant institutes, and the response rates for the 1st, 2nd ...
양, 동욱 +13 more
core
Artificial Cells: Perspective on Reconstructing Biological Cells and “Out of the Box” Innovations
The first artificial cell was artificial red blood cells (RBCs) (Chang, 1957), RBC is one of the most important cells because our cells, tissues, organs, and whole human being need it for survival. Even more exciting is innovating this to result in artificial cells of unlimited configurations, contents, and applications.
Thomas Ming Swi Chang
wiley +1 more source
ABSTRACT Massive transfusion protocols are essential in trauma resuscitation but may inadvertently increase the risk of acute hemolytic transfusion reactions (AHTRs), which are typically caused by ABO incompatibility. Recognition is difficult because signs of hemolysis can mimic trauma‐related hemorrhage or coagulopathy.
Mohammad Javad Entezari Meybodi +3 more
wiley +1 more source
The Necessity of Routine Pre-operative Group and Save Testing for Emergency Appendectomies. [PDF]
Ibrahim B +6 more
europepmc +1 more source
A Nationwide Study on Pretransfusion Testing for 10 Years in Korea Using Health Insurance Review and Assessment Claims Data. [PDF]
Park JH, Chung Y, Ko DH, Kim H.
europepmc +1 more source
Serological and Clinical Evaluation of Incompatible Crossmatches Encountered in Pre-transfusion Testing. [PDF]
Badoni A, Kusum A, Raturi M.
europepmc +1 more source
Is It Time to Switch from Conventional Coombs Crossmatching to the Type and Screen Protocol? [PDF]
Baiju NM +5 more
europepmc +1 more source
Hyperbilirubinemia in a glucose-6-phosphate dehydrogenase-deficient newborn: Confounding role of maternal anti-In<sup>b</sup> in finding the crossmatch-compatible blood for exchange transfusion. [PDF]
Joshi SR +6 more
europepmc +1 more source

